Business

Here it is – a simple, easy to perform, highly reproducible plan for manufacturer pre-market approval or laboratory self-validation for the intended use of endoscopic mucosal gastrointestinal biopsies. These specimens are extremely common...

I recently read with interest a post by Dr. Bruce Friedman over at labsoftnews.com about “Online Bidding for Best Price for Orthopedic Surgery with Medibid” and the business model of medical tourism within US facilities through a...

Visit Applied Spectral Imaging at two shows this August - come see our latest pathology quantitative diagnostic aid and learn more about ASI’s GenASIs ™ Pathology Suite. NSH 2014, the 40th Annual NSH Convention in Austin, Texas, USA –...

Visit our booth (#37) at ECP to learn how our quantitative pathology solutions can help analyze complex relationships among tumor and immune cells in the tumor micro-environment. Our imaging systems and reagent solutions can deliver per-cell...

If you ask anyone who has been involved with digital pathology for the past 5 years or more that has studied the market from their respective perches, "Is the digital pathology market worth $200 million or $2 billion?" their answer would...

Chicago, IL and San Diego, CA -- July 30, 2014 -- GTCR, a leading private equity firm, today announced that it has acquired XIFIN, Inc. ("XIFIN" or "the Company"). XIFIN, headquartered in San Diego, California, is a leading provider of...